Rocket Companies RKT 深 滬
等待開盤 11-26 09:30:00 美东时间
19.66
+1.540
+8.50%
華盛通- 最 高19.78
- 今 開18.27
- 成交量 3882.31万股
- 最 低 18.25
- 昨 收 18.12
- 總市值 553.23亿
- 52周最高 22.555
- 市盈率 靜 94.43
- 換手率 1.38%
- 52周最低 9.26
- 委 比 11.11%
- 總股本 28.14亿
- 歷史最高 40.08
- 量 比 1.04
- 振 幅 8.44%
- 歷史最低 5.17
- 每 手 1
- 風險率 2.86%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Rocket Companies (RKT) Stock Surges As December Rate Cut Odds Fuel Mortgage Optimism
Rocket Companies shares traded higher Tuesday, propelled by a dramatic shift in Federal Reserve expectations.
今天 05:15
Long Bitcoin, Short MicroStrategy: Citron Research 'Proud Of The Timing' One Year Later
Short seller Citron Research, led by Andrew Left, made a prediction one year ago.
11-22 02:55
'No One's Buying Homes Here': Cramer Warns On This Housing Stock
Cramer prefers Netflix (NFLX) over FuboTV (FUBO). Rocket Companies (RKT) and Regeneron Pharmaceuticals (REGN) also discussed. FDA approves new drug for Regeneron.
11-22 02:51
8 Financials Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
11-21 01:35
美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；
今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元
11-20 10:28
Dan Loeb Raises Microsoft Stake 175% In Big-Tech Push, Dumps Workday And More
Dan Loeb's Third Point doubled its Microsoft stake and boosted Meta, Amazon, and Nvidia while fully exiting Workday and multiple industrial names in Q3.
11-20 04:46
Best AI productivity beneficiary stocks - Goldman
Goldman Sachs has identified a new group of “AI productivity beneficiaries,” highlighting companies best positioned to see earnings lift from automation-driven efficiency gains. Strategist David Kosti...
11-18 21:52
The Next Wave Of AI Winners? Investors Shift Focus Beyond Nvidia
Goldman Sachs says investors are shifting toward companies quietly using AI to cut costs and drive productivity-led growth.
11-17 23:47
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
